Azeria Therapeutics

OverviewSuggest Edit

Azeria Therapeutics is a company that provides a cancer drug intended to aid in the treatment of breast and prostate cancer patients. It develops a pipeline of small molecules designed to selectively inhibit pioneer factors, enabling medical professionals to treat cancer patients.
TypePrivate
Founded2017
HQCambridge, GB
Websiteazeriatherapeutics.com

Locations

Azeria Therapeutics is headquartered in
Cambridge, United Kingdom

Location Map

Latest Updates

Employees (est.) (Aug 2021)3
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Azeria Therapeutics

Steve Myatt

Steve Myatt

Chief Executive Officer, Director
Jason Carroll

Jason Carroll

Founder and Chief Scientific Officer, Director
Julian Blagg

Julian Blagg

VP Drug Discovery
Jon Roffey

Jon Roffey

Director of Chemistry
Caryn Ross-Innes

Caryn Ross-Innes

Chief Executive Officer, Director
Nimesh Joseph

Nimesh Joseph

Associate Director, Target Evaluation
Show more

Azeria Therapeutics Office Locations

Azeria Therapeutics has an office in Cambridge
Cambridge, GB (HQ)
University of Cambridge, Robinson Way
Show all (1)

Azeria Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Azeria Therapeutics total Funding

$46.5 m

Azeria Therapeutics latest funding size

$41.32 m

Time since last funding

2 years ago

Azeria Therapeutics investors

Azeria Therapeutics's latest funding round in November 2019 was reported to be $41.3 m. In total, Azeria Therapeutics has raised $46.5 m
Show all financial metrics

Azeria Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

100/100

SecurityScorecard logo

Azeria Therapeutics Online and Social Media Presence

Embed Graph

Azeria Therapeutics Frequently Asked Questions

  • When was Azeria Therapeutics founded?

    Azeria Therapeutics was founded in 2017.

  • Who are Azeria Therapeutics key executives?

    Azeria Therapeutics's key executives are Steve Myatt, Jason Carroll and Julian Blagg.

  • How many employees does Azeria Therapeutics have?

    Azeria Therapeutics has 3 employees.

  • Who are Azeria Therapeutics competitors?

    Competitors of Azeria Therapeutics include Numab, Cybrexa Therapeutics and Sonnet BioTherapeutics.

  • Where is Azeria Therapeutics headquarters?

    Azeria Therapeutics headquarters is located at University of Cambridge, Robinson Way, Cambridge.

  • Where are Azeria Therapeutics offices?

    Azeria Therapeutics has an office in Cambridge.

  • How many offices does Azeria Therapeutics have?

    Azeria Therapeutics has 1 office.